Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

The Changing Landscape of the Biotech Pharma Deal

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
495 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Aug 13, 2010

Biotech and Pharma industry experts converse on deal making trends. Learn how you can position your technology and/or company for success in the current environment.

Our seasoned panel discusses the evolution of deal models in the life science industry from the 1980s to present day. Our panelists touch upon issues relating to the size of the deals, valuations, early stage /late stage deals, and recent acquisition activity (Takeda/Millennium; AstraZeneca/MedImmune; Imclone/Lilly). A must watch for anyone interested in Biotech Pharma deal making.

Moderator:
- Dr. Mark DeWyngaert - MD Huron Consulting Group

Panelists:
- Dr. Christine T. Fischette, President, Enzo Therapeutics, Inc.
- Tamar D. Howson, MS, MBA, JSB Partners
- Ed Saltzman, President, DefinedHealth

  • likes, 1 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more